AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong support for the U.S. Food and Drug Administration’s ...
Before 2022, software development primarily focused on reliability and functionality testing, given the predictable nature of traditional systems and apps. With the rise of generative AI (genAI) ...
Altogether, £27m is now available to fund the AI Security Institute’s work to collaborate on safe, secure artificial intelligence.
Forbes contributors publish independent expert analyses and insights. A common trope today is that artificial intelligence is too complex to understand and impossible to control. Some pioneering work ...
Cardiovascular diseases remain the leading global cause of mortality, claiming nearly 18 million lives each year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results